{"transactions":[{"id":803955,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-04-21T21:00:04.000Z","date":"2026-04-18","kind":"exercise","planned":false,"acquired":true,"shares":838,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion."},{"field":"shares","element":"transactionShares","label":"F1","text":"Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share (\"ADS\") currently represents twenty (20) Ordinary Shares (\"ADS Ratio Change\"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On April 18, 2024, following the conclusion of the Issuer's annual general meeting of shareholders for 2024, the Reporting Person was granted 2,514 RSUs under the Amarin Corporation plc 2020 Stock Incentive Plan (the \"Plan\"). These RSUs vest in three equal installments on each of April 18, 2025, April 18, 2026 and April 18, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share (\"ADS\") currently represents twenty (20) Ordinary Shares (\"ADS Ratio Change\"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share (\"ADS\") currently represents twenty (20) Ordinary Shares (\"ADS Ratio Change\"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share (\"ADS\") currently represents twenty (20) Ordinary Shares (\"ADS Ratio Change\"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change."}],"balance_after":838,"derivative":{"exercise_price":0,"underlying":"American Depositary Shares","underlying_shares":838},"source":{"system":"sec-edgar","filing":"0001193125-26-167119","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/897448/000119312526167119/ownership.xml","form_type":"4"}},{"id":803954,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2026-04-21T21:00:04.000Z","date":"2026-04-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":403,"price":14.98,"value":6036.94,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share (\"ADS\") currently represents twenty (20) Ordinary Shares (\"ADS Ratio Change\"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities."},{"field":"shares","element":"transactionShares","label":"F1","text":"Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share (\"ADS\") currently represents twenty (20) Ordinary Shares (\"ADS Ratio Change\"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share (\"ADS\") currently represents twenty (20) Ordinary Shares (\"ADS Ratio Change\"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change."}],"balance_after":836,"source":{"system":"sec-edgar","filing":"0001193125-26-167119","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897448/000119312526167119/ownership.xml","form_type":"4"}},{"id":803953,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2026-04-21T21:00:04.000Z","date":"2026-04-18","kind":"exercise","planned":false,"acquired":true,"shares":838,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share (\"ADS\") currently represents twenty (20) Ordinary Shares (\"ADS Ratio Change\"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On April 18, 2024, following the conclusion of the Issuer's annual general meeting of shareholders for 2024, the Reporting Person was granted 2,514 RSUs under the Amarin Corporation plc 2020 Stock Incentive Plan (the \"Plan\"). These RSUs vest in three equal installments on each of April 18, 2025, April 18, 2026 and April 18, 2027."},{"field":"shares","element":"transactionShares","label":"F1","text":"Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share (\"ADS\") currently represents twenty (20) Ordinary Shares (\"ADS Ratio Change\"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share (\"ADS\") currently represents twenty (20) Ordinary Shares (\"ADS Ratio Change\"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change."}],"balance_after":1239,"source":{"system":"sec-edgar","filing":"0001193125-26-167119","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897448/000119312526167119/ownership.xml","form_type":"4"}},{"id":849501,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-03-12T01:15:47.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":25640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Options will vest in full on March 9, 2027, subject to continuous service through the vesting date."}],"balance_after":25640,"derivative":{"exercise_price":11.61,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":25640},"source":{"system":"sec-edgar","filing":"0001104659-26-026583","document":"tm268588-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465926026583/tm268588-6_4seq1.xml","form_type":"4"}},{"id":1167961,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-04-23T01:00:09.000Z","date":"2025-04-18","kind":"exercise","planned":false,"acquired":true,"shares":838,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion."},{"field":"shares","element":"transactionShares","label":"F1","text":"Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share (\"ADS\") currently represents twenty (20) Ordinary Shares (\"ADS Ratio Change\"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On April 18, 2024, following the conclusion of the Issuer's annual general meeting of shareholders for 2024, the Reporting Person was granted an award that vests in three equal installments on each of April 18, 2025, April 18, 2026 and April 18, 2027"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable"},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share (\"ADS\") currently represents twenty (20) Ordinary Shares (\"ADS Ratio Change\"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share (\"ADS\") currently represents twenty (20) Ordinary Shares (\"ADS Ratio Change\"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share (\"ADS\") currently represents twenty (20) Ordinary Shares (\"ADS Ratio Change\"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change."}],"balance_after":1676,"derivative":{"exercise_price":0,"underlying":"American Depositary Shares","underlying_shares":838},"source":{"system":"sec-edgar","filing":"0000950170-25-056929","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/897448/000095017025056929/ownership.xml","form_type":"4"}},{"id":1167960,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2025-04-23T01:00:09.000Z","date":"2025-04-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":437,"price":9.11,"value":3981.07,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share (\"ADS\") currently represents twenty (20) Ordinary Shares (\"ADS Ratio Change\"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities."},{"field":"shares","element":"transactionShares","label":"F1","text":"Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share (\"ADS\") currently represents twenty (20) Ordinary Shares (\"ADS Ratio Change\"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share (\"ADS\") currently represents twenty (20) Ordinary Shares (\"ADS Ratio Change\"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change."}],"balance_after":401,"source":{"system":"sec-edgar","filing":"0000950170-25-056929","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897448/000095017025056929/ownership.xml","form_type":"4"}},{"id":1167959,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2025-04-23T01:00:09.000Z","date":"2025-04-18","kind":"exercise","planned":false,"acquired":true,"shares":838,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share (\"ADS\") currently represents twenty (20) Ordinary Shares (\"ADS Ratio Change\"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On April 18, 2024, following the conclusion of the Issuer's annual general meeting of shareholders for 2024, the Reporting Person was granted an award that vests in three equal installments on each of April 18, 2025, April 18, 2026 and April 18, 2027"},{"field":"shares","element":"transactionShares","label":"F1","text":"Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share (\"ADS\") currently represents twenty (20) Ordinary Shares (\"ADS Ratio Change\"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share (\"ADS\") currently represents twenty (20) Ordinary Shares (\"ADS Ratio Change\"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change."}],"balance_after":838,"source":{"system":"sec-edgar","filing":"0000950170-25-056929","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897448/000095017025056929/ownership.xml","form_type":"4"}},{"id":1279285,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-02-07T21:22:54.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":54343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options shall vest (i) 50% on February 5, 2026 and (ii) 50% on February 5, 2027, in each case subject to continuous service through such vesting date."}],"balance_after":54343,"derivative":{"exercise_price":2.04,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":54343},"source":{"system":"sec-edgar","filing":"0001104659-25-010568","document":"tm255864-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465925010568/tm255864-9_4seq1.xml","form_type":"4"}},{"id":1473731,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-statutory Stock Option","published_at":"2024-06-20T20:57:15.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") and options upon the conclusion of the Issuer's 2024 annual meeting of stockholders. 100% of the RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":30000,"derivative":{"exercise_price":16.16,"exercise_date":"2025-06-17","expiration_date":"2034-06-16","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-24-073447","document":"tm2417570-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000110465924073447/tm2417570-3_4seq1.xml","form_type":"4"}},{"id":1473730,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T20:57:15.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":13923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") and options upon the conclusion of the Issuer's 2024 annual meeting of stockholders. 100% of the RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":122625,"source":{"system":"sec-edgar","filing":"0001104659-24-073447","document":"tm2417570-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000110465924073447/tm2417570-3_4seq1.xml","form_type":"4"}},{"id":1538640,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-04-19T20:35:52.000Z","date":"2024-04-18","kind":"grant","planned":false,"acquired":true,"shares":50287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On April 18, 2024, following the conclusion of the Issuer's annual general meeting of shareholders for 2024, the Reporting Person was granted an award of 50,287 RSUs under the Plan and the Policy. These RSUs vest in three equal installments on each of April 18, 2025, April 18, 2026 and April 18, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":50287,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":50287},"source":{"system":"sec-edgar","filing":"0000950170-24-046054","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897448/000095017024046054/ownership.xml","form_type":"4"}},{"id":1538639,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-19T20:35:52.000Z","date":"2024-04-18","kind":"grant","planned":false,"acquired":true,"shares":179795,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 18, 2024, following the conclusion of the Issuer's annual general meeting of shareholders for 2024, the Reporting Person was granted an option to purchase 179,795 Ordinary Shares under the Plan and the Policy. The shares subject to this option shall vest and become exercisable over three years, with 33% to vest on the first anniversary of the grant date and the remaining balance vesting in equal quarterly installments over the subsequent two years on the first day of each April, July, October and January."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":179795,"derivative":{"exercise_price":0.87,"expiration_date":"2034-04-18","underlying":"Ordinary Shares","underlying_shares":179795},"source":{"system":"sec-edgar","filing":"0000950170-24-046054","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897448/000095017024046054/ownership.xml","form_type":"4"}},{"id":1573478,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-03-19T00:00:26.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":54343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Options shall vest (i) 50% on March 14, 2025 and (ii) 50% on March 14, 2026, in each case subject to continuous service through such vesting date."}],"balance_after":94009,"derivative":{"exercise_price":3.38,"expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":54343},"source":{"system":"sec-edgar","filing":"0001104659-24-035724","document":"tm249071-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465924035724/tm249071-5_4seq1.xml","form_type":"4"}},{"id":1573477,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-03-19T00:00:26.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":39666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options shall vest upon the Company's 2024 annual shareholders meeting subject to the Non-Employee Director's continuous service through immediately prior to the convening of such meeting, with the date of grant being March 14, 2024."}],"balance_after":39666,"derivative":{"exercise_price":3.38,"expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":39666},"source":{"system":"sec-edgar","filing":"0001104659-24-035724","document":"tm249071-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465924035724/tm249071-5_4seq1.xml","form_type":"4"}},{"id":1700424,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-12-27T02:53:27.000Z","date":"2023-12-21","kind":"grant","planned":false,"acquired":true,"shares":10461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests immediately prior to the Company's 2024 annual shareholders meeting."}],"balance_after":10461,"derivative":{"exercise_price":2.39,"expiration_date":"2033-12-21","underlying":"Common Stock","underlying_shares":10461},"source":{"system":"sec-edgar","filing":"0001104659-23-129364","document":"tm2333426-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465923129364/tm2333426-1_4seq1.xml","form_type":"4"}},{"id":1825214,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-07-22T01:16:59.000Z","date":"2023-07-21","kind":"grant","planned":false,"acquired":true,"shares":60268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On July 21, 2023, following the conclusion of the Issuer's annual general meeting of shareholders for 2023, the Reporting Person was granted an award of 60,268 RSUs under the Plan and the Policy. These RSUs vest in full upon the earlier of the one-year anniversary of the grant date and the annual general meeting of shareholders in such anniversary year.  The RSUs are subject to deferred settlement upon the director's separation of service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Not applicable."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":60268,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":60268},"source":{"system":"sec-edgar","filing":"0000950170-23-033912","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/897448/000095017023033912/ownership.xml","form_type":"4"}},{"id":1825213,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-07-22T01:16:59.000Z","date":"2023-07-21","kind":"grant","planned":false,"acquired":true,"shares":94866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"In connection with the Reporting Person's initial appointment to the Issuer's board of directors, on July 21, 2023 the Reporting Person was granted a one-time grant of 94,866 RSUs under the Plan and the Policy.  These RSUs vest in equal annual installments over three years from the date of the Reporting Person's initial appointment to the Issuer's board of directors. The RSUs are subject to deferred settlement upon the director's separation of service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Not applicable."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":94866,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":94866},"source":{"system":"sec-edgar","filing":"0000950170-23-033912","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/897448/000095017023033912/ownership.xml","form_type":"4"}},{"id":1825212,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-22T01:16:59.000Z","date":"2023-07-21","kind":"grant","planned":false,"acquired":true,"shares":180804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 21, 2023, following the conclusion of the Issuer's annual general meeting of shareholders for 2023, the Reporting Person was granted an option to purchase 180,804 Ordinary Shares under the Plan and the Policy. This option shall vest and become exercisable upon the earlier of the one-year anniversary of the grant date and the annual general meeting of shareholders in such anniversary year."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":180804,"derivative":{"exercise_price":1.12,"expiration_date":"2033-07-21","underlying":"Ordinary Shares","underlying_shares":180804},"source":{"system":"sec-edgar","filing":"0000950170-23-033912","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897448/000095017023033912/ownership.xml","form_type":"4"}},{"id":1825211,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-22T01:16:59.000Z","date":"2023-07-21","kind":"grant","planned":false,"acquired":true,"shares":258598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the Reporting Person's initial appointment to the Issuer's board of directors, on July 21, 2023 the Reporting Person was granted a one-time option to purchase 284,598 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the \"Plan\") and the Non-Employee Director Compensation Policy, as revised in May 2023 (the \"Policy\").  This option shall vest and become exercisable in equal annual installments over three years from the date of the Reporting Person's initial appointment to the Issuer's board of directors."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":284598,"derivative":{"exercise_price":1.12,"expiration_date":"2033-07-21","underlying":"Ordinary Shares","underlying_shares":284598},"source":{"system":"sec-edgar","filing":"0000950170-23-033912","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897448/000095017023033912/ownership.xml","form_type":"4"}},{"id":1880189,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-statutory Stock Option","published_at":"2023-05-24T21:47:38.000Z","date":"2023-05-22","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") and options upon the conclusion of the Issuer's 2023 annual meeting of stockholders. 100% of the RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":13.64,"exercise_date":"2024-05-22","expiration_date":"2033-05-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-23-064209","document":"tm2316873-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000110465923064209/tm2316873-1_4seq1.xml","form_type":"4"}},{"id":1880188,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-24T21:47:38.000Z","date":"2023-05-22","kind":"grant","planned":false,"acquired":true,"shares":16495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") and options upon the conclusion of the Issuer's 2023 annual meeting of stockholders. 100% of the RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":108702,"source":{"system":"sec-edgar","filing":"0001104659-23-064209","document":"tm2316873-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000110465923064209/tm2316873-1_4seq1.xml","form_type":"4"}},{"id":2289871,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-statutory Stock Option","published_at":"2022-04-27T22:47:43.000Z","date":"2022-04-25","kind":"grant","acquired":true,"shares":10000,"price":10000,"value":100000000.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":17.79,"exercise_date":"2023-04-25","expiration_date":"2032-04-24","underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001567619-22-009041","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000156761922009041/doc1.xml","form_type":"4"}},{"id":2289870,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-27T22:47:43.000Z","date":"2022-04-25","kind":"grant","acquired":true,"shares":12647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") and options upon the conclusion of the Issuer's 2022 annual meeting of stockholders. 100% of the RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":92207,"source":{"system":"sec-edgar","filing":"0001567619-22-009041","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000156761922009041/doc1.xml","form_type":"4"}},{"id":2296619,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-04-15T19:52:00.000Z","date":"2022-04-13","kind":"grant","acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant."}],"balance_after":33000,"derivative":{"exercise_price":5.11,"expiration_date":"2032-04-13","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001104659-22-046449","document":"tm2212851-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465922046449/tm2212851-5_4seq1.xml","form_type":"4"}},{"id":2676433,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-09T20:25:16.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant."}],"balance_after":28000,"derivative":{"exercise_price":4.29,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001104659-21-078785","document":"tm2119245-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465921078785/tm2119245-1_4seq1.xml","form_type":"4"}},{"id":2703790,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-21T00:15:52.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":17482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") upon the conclusion of the Issuer's 2021 annual meeting of stockholders. 100% of the RSUs will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":79560,"source":{"system":"sec-edgar","filing":"0001567619-21-010829","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000156761921010829/doc1.xml","form_type":"4"}},{"id":2952414,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-09T21:05:47.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant."}],"balance_after":23000,"derivative":{"exercise_price":3.15,"expiration_date":"2030-12-08","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001104659-20-133628","document":"tm2038059-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465920133628/tm2038059-2_4seq1.xml","form_type":"4"}},{"id":3168476,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-28T20:38:53.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":16917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). 100% of the RSUs will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":62078,"source":{"system":"sec-edgar","filing":"0001567619-20-008547","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000156761920008547/doc1.xml","form_type":"4"}},{"id":3271843,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-15T00:39:16.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":27383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each annual anniversary of the date of grant."}],"balance_after":27383,"derivative":{"exercise_price":4.17,"expiration_date":"2030-02-12","underlying":"Common Stock","underlying_shares":27383},"source":{"system":"sec-edgar","filing":"0001104659-20-022126","document":"tm208184-4_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465920022126/tm208184-4_form4.xml","form_type":"4"}},{"id":3512335,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-25T01:58:15.000Z","date":"2019-04-24","kind":"grant","acquired":true,"shares":16399,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). 100% of the RSUs will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":45161,"source":{"system":"sec-edgar","filing":"0001104659-19-031862","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000110465919031862/a4.xml","form_type":"4"}},{"id":3956394,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Odysseas Kostas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-26T20:55:17.000Z","date":"2018-04-24","kind":"grant","acquired":true,"shares":14249,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). 100% of the RSUs will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":28762,"source":{"system":"sec-edgar","filing":"0001179110-18-005892","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911018005892/edgar.xml","form_type":"4"}},{"id":4123964,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":51851,"kind":"person","name":"Odysseas Kostas D","position":1,"cik":"0001483080","reported_name":"Kostas Odysseas D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-21T23:23:21.000Z","date":"2017-12-19","kind":"grant","acquired":true,"shares":14513,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14513,"source":{"system":"sec-edgar","filing":"0001179110-17-015803","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911017015803/edgar.xml","form_type":"4"}}]}